Format

Send to

Choose Destination
Br J Haematol. 2019 Aug;186(3):e24-e27. doi: 10.1111/bjh.15859. Epub 2019 Mar 11.

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas.

Author information

1
Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
2
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
3
Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.
4
Division of Hematology and Oncology, CISSS-MC - Charles LeMoyne Hospital, Greenfield Park, QC, Canada.
5
Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa, Iowa City, IA, USA.
6
Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
7
Division of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
8
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
9
Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, BC, Canada.
10
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

KEYWORDS:

IPI ; PIT ; NCCN-IPI; peripheral T-cell lymphoma; prognostic factors

PMID:
30859549
DOI:
10.1111/bjh.15859

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center